Last $169.10 USD
Change Today -0.44 / -0.26%
Volume 267.3K
BCR On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 5:15 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

cr bard inc (BCR) Snapshot

Open
$169.46
Previous Close
$169.54
Day High
$169.95
Day Low
$168.71
52 Week High
12/5/14 - $174.46
52 Week Low
02/3/14 - $125.00
Market Cap
12.7B
Average Volume 10 Days
560.5K
EPS TTM
$6.77
Shares Outstanding
74.9M
EX-Date
01/22/15
P/E TM
25.0x
Dividend
$0.88
Dividend Yield
0.51%
Current Stock Chart for CR BARD INC (BCR)

cr bard inc (BCR) Related Businessweek News

No Related Businessweek News Found

cr bard inc (BCR) Details

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular products, including percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, covered stents, and vascular grafts; vena cava filters; biopsy devices; and temporary pacing electrode catheters for the treatment of peripheral vascular disease and heart arrhythmias. The company’s urology products include Foley catheters to reduce the rate of urinary tract infections; surgical slings to treat stress urinary incontinence; fecal incontinence products; devices for the treatment of pelvic floor and vaginal prolapse; brachytherapy services, devices, and radioactive seeds to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal; catheter stabilization devices; and products for therapeutic hypothermia. It also provides specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers and other diseases and disorders. In addition, the company offers surgical specialty products, such as implanted grafts and fixation devices for hernia and soft tissue repair products; surgical sealants for intraoperative sealing of air leaks in thoracic surgery; and other products that include irrigation, wound drainage, and original equipment manufacturers’ products. It sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities, as well as through hospital/surgical supply and other medical specialty distributors. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.

13,000 Employees
Last Reported Date: 02/19/14
Founded in 1907

cr bard inc (BCR) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.1M
President, Chief Operating Officer and Direct...
Total Annual Compensation: $887.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $540.0K
Group President
Total Annual Compensation: $660.0K
Group President
Total Annual Compensation: $560.0K
Compensation as of Fiscal Year 2013.

cr bard inc (BCR) Key Developments

C. R. Bard, Inc. Declares Quarterly Dividend, Payable on February 6, 2015

The board of directors of C. R. Bard Inc. declared a regular quarterly dividend of 22 cents per share on Bard's common stock. The current indicated annual dividend rate is 88 cents per share. The dividend is payable on February 6, 2015 to shareholders of record at the close of business on January 26, 2015.

CR Bard Seeks Acquisitions

CR Bard Inc. (NYSE:BCR) is seeking acquisitions. Chris Holland, Chief Financial Officer of CR Bard, said, "We've got a small product portfolio that will continue to expand both through indications and additional acquisitions probably." Bard added, "We would have to really dramatically increase the dividend, and the last thing we don't want to be able to do is not pursue a large acquisition because we've backed ourselves in a corner. So I think everybody gets that. I think we do have the ability, because of the cash flow-generating nature of the business, to do both of those things in combination in the ordinary course: continue to buy back stock at a healthy rate over time and make acquisitions of reasonable size. We can do both of those and we will continue to look to do both of those."

CR Bard Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 09:00 AM

CR Bard Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 09:00 AM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Christopher S. Holland, Chief Financial Officer and Senior Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BCR:US $169.10 USD -0.44

BCR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CareFusion Corp $59.18 USD +0.04
Edwards Lifesciences Corp $130.75 USD +1.17
Endo International PLC $72.10 USD +0.34
Hospira Inc $62.60 USD -0.07
Varian Medical Systems Inc $88.44 USD +0.69
View Industry Companies
 

Industry Analysis

BCR

Industry Average

Valuation BCR Industry Range
Price/Earnings 16.2x
Price/Sales 3.9x
Price/Book 6.9x
Price/Cash Flow 15.3x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CR BARD INC, please visit www.crbard.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.